Morepen Laboratories Ltd | Industry : (Pharmaceuticals) | |
---|---|---|
|
|
|
|
|
|
|
|
|
Mar '2025 | Mar '2024 | Mar '2023 | Mar '2022 | Mar '2021 | |
---|---|---|---|---|---|
SOURCES OF FUNDS : | |||||
Equity Share Capital | 109.58 | 102.23 | 102.23 | 95.56 | 89.96 |
Reserves | 1,071.92 | 786.80 | 677.89 | 476.36 | 311.26 |
Equity Share Warrants | 0.00 | 0.00 | 0.00 | 26.25 | 43.75 |
Equity Application Money | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Total Shareholders Funds | 1,181.50 | 889.03 | 780.12 | 598.17 | 444.97 |
Secured Loans | 58.96 | 28.19 | 25.16 | 18.57 | 17.05 |
Unsecured Loans | 36.55 | 0.00 | 0.00 | 0.00 | 0.00 |
Total Debt | 95.51 | 28.19 | 25.16 | 18.57 | 17.05 |
Other Liabilities | 36.82 | 32.03 | 30.83 | 28.60 | 26.06 |
Total Liabilities | 1,313.83 | 949.25 | 836.11 | 645.34 | 488.08 |
APPLICATION OF FUNDS : | |||||
Gross Block | 648.76 | 477.36 | 512.07 | 479.46 | 516.17 |
Less: Accumulated Depreciation | 282.88 | 260.83 | 341.25 | 323.35 | 372.14 |
Less:Impairment of Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Block | 365.88 | 216.53 | 170.82 | 156.11 | 144.03 |
Lease Adjustments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capital Work in Progress | 28.34 | 24.45 | 17.01 | 14.15 | 1.96 |
Investments | 204.97 | 126.18 | 117.84 | 117.79 | 118.78 |
Current Assets, Loans & Advances | |||||
Inventories | 286.39 | 220.15 | 211.35 | 258.25 | 169.61 |
Sundry Debtors | 293.75 | 316.89 | 255.47 | 221.87 | 155.52 |
Cash and Bank Balance | 46.33 | 50.48 | 55.90 | 45.55 | 66.98 |
Loans and Advances | 402.51 | 255.40 | 208.12 | 151.09 | 100.68 |
Total Current Assets | 1,028.98 | 842.91 | 730.85 | 676.76 | 492.79 |
Less : Current Liabilities and Provisions | |||||
Current Liabilities | 382.79 | 304.76 | 251.83 | 375.83 | 355.37 |
Provisions | 17.60 | 23.05 | 14.91 | 9.61 | 4.05 |
Total CL & Provisions | 400.39 | 327.81 | 266.74 | 385.44 | 359.42 |
Net Current Assets | 628.59 | 515.10 | 464.11 | 291.33 | 133.38 |
Miscellaneous Expenses not written off | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Deferred Tax Assets | 15.64 | 10.38 | 9.57 | 9.18 | 0.00 |
Deferred Tax Liability | 22.62 | 12.63 | 12.26 | 11.67 | 0.00 |
Net Deferred Tax | -6.98 | -2.25 | -2.69 | -2.49 | 0.00 |
Other Assets | 93.04 | 69.23 | 69.02 | 68.45 | 89.95 |
Total Assets | 1,313.83 | 949.25 | 836.11 | 645.34 | 488.09 |
Contingent Liabilities | 16.23 | 7.09 | 6.66 | 1.64 | 0.93 |